Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy?

Abstract

Telomerase activation is observed in almost 90% of human cancers but not in normal tissues of somatic origin and thus is a critical step for multistep carcinogenesis. A more thorough understanding of telomerase regulation may provide not only a molecular basis of cancer progression but also as a way to manipulate telomerase activity as a potential therapeutic modality. Recent progress in studies on telomerase regulation has shown that telomerase activation is achieved at various steps, including transcriptional and post-transcriptional levels of the telomerase reverse transcriptase (hTERT) gene. Although a number of potentially important mechanisms of telomerase activation have been proposed, none of the current models can fully explain tumor-specific activation of telomerase, suggesting a need for further extensive analysis. This review includes a summary of recent works on telomerase regulation and a discussion of how we can overcome this situation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Akalin A, Elmore LW, Forsythe HL, Amaker BA, McCollum ED, Nelson PS, Ware JL, Holt SE . 2001 Cancer Res. 61: 4791–4796

  • Aldous WK, Marean AJ, DeHart MJ, Matej LA, Moore KH . 1999 Cancer 85: 1523–1529

  • Allsopp RC, Vaziri H, Patterson C . 1992 Proc. Natl. Acad. Sci. USA 89: 10114–10118

  • Alitalo K, Koskinen P, Makela TP, Saksela K, Sistonen L, Winqvist R . 1987 Biochim. Biophys Acta. 907: 1–32

  • Blackburn EH . 1991 Nature 350: 569–573

  • Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE . 1998 Science 279: 349–352

  • Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR . 1995 EMBO J. 14: 4240–4248

  • Burger AM, Double JA, Newell DR . 1997 Eur. J. Cancer 33: 638–644

  • Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA . 1999 Cell 97: 527–538

  • Clark GM, Osborne CK, Levitt D, Wu F, Kim NW . 1997 J. Natl. Cancer Inst. 89: 1874–1881

  • Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR . 2000 Neoplasia 2: 426–432

  • Cong YS, Bacchetti S . 2000 J. Biol. Chem. 275: 35665–35668

  • Cong YS, Wen J, Bacchetti S . 1999 Hum. Mol. Genet. 8: 137–142

  • Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S . 1992 EMBO J. 11: 1921–1929

  • Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S . 1995 Blood 85: 2315–2320

  • Crowe DL, Nguyen DC, Tsang KJ, Kyo S . 2001 Nucleic Acids Res. 29: 2789–2794

  • Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, Marriott A, Khoudoli G, Parkinson EK, Cooper CS, Newbold RF . 1999 J. Natl. Cancer Inst. 91: 37–45

  • Dessain SK, Yu H, Reddel RR, Beijersbergen RL, Weinberg RA . 2000 Cancer Res. 60: 537–541

  • Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC . 1999 Cancer Res. 59: 6087–6090

  • Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C . 1999 Mol. Cell. Biol. 19: 5504–5511

  • Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J . 2001 Cancer Res. 61: 7594–7602

  • Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS . 1997 Blood 90: 182–193

  • Feng J, Funk WD, Wang SS, Weinrich AAA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrew WH, Greider CW, Villeponteau B . 1995 Science 269: 1236–1241

  • Fujimoto K, Kyo S, Takakura M, Kanaya T, Kitagawa Y, Itoh H, Takahashi M, Inoue M . 2000 Nucleic Acids Res. 28: 2557–2562

  • Fuxe J, Akusjarvi G, Goike HM, Roos G, Collins VP, Pettersson RF . 2000 Cell Growth Differ. 11: 373–384

  • Gewin L, Galloway DA . 2001 J. Virol. 75: 7198–7201

  • Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA . 1999 Oncogene 18: 1219–1226

  • Greider CW, Blackburn EH . 1989 Nature 337: 331–337

  • Gu J, Kagawa S, Takakura M, Kyo S, Inoue M, Roth JA, Fang B . 2000 Cancer Res. 60: 5359–5364

  • Gunes C, Lichtsteiner S, Vasserot AP, Englert C . 2000 Cancer Res. 60: 2116–2121

  • Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA . 1999 Nature 400: 464–468

  • Harle-Bachor C, Boukamp P . 1996 Proc. Natl. Acad. Sci. USA 93: 6476–6481

  • Harley CB, Futcher BA, Greider CW . 1990 Nature 345: 458–460

  • Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE . 1997 Cell 89: 341–347

  • Heinzel T, Lavinsky RM, Mullen TM, Sonderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo D, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG . 1997 Nature 387: 43–48

  • Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA . 1996 J. Natl. Cancer Inst. 88: 116–122

  • Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW . 1995a Nat. Med. 1: 249–255

  • Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M . 1995b J. Immunol. 155: 3711–3715

  • Holt SE, Aisner D, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Morin GB, Toft DO, Shay JW, Wright WE, White MA . 1999 Genes Dev. 13: 817–826

  • Holt SE, Aisner DL, Shay JW, Wright WE . 1997 Proc. Natl. Acad. Sci. USA 94: 10687–10692

  • Horikawa I, Cable PL, Afshari C, Barrett JC . 1999 Cancer Res. 59: 826–830

  • Kagawa S, Fujiwara T, Kadowaki Y, Fukazawa T, Sok-Joo R, Roth JA, Tanaka N . 1999 Cell Death Differ. 6: 765–772

  • Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M . 2000 Clin. Cancer Res. 6: 1239–1247

  • Kang SS, Kwon T, Kwon DY, Do SI . 1999 J. Biol. Chem. 274: 13085–13090

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015

  • Kinoshita T, Shirasawa H, Shino Y, Moriya H, Desbarats L, Eilers M, Shimizu B . 1997 Virology 232: 53–61

  • Klingelhutz AJ, Foster SA, McDougall JK . 1996 Nature 380: 79–82

  • Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S . 2000 Hum. Gene Ther. 10: 1397–1406

  • Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Alnemri ES, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S . 2001 Cancer Res. 61: 5796–5802

  • Kunimura C, Kikuchi K, Ahmed N, Shimizu A, Yasumoto S . 1998 Oncogene 17: 187–197

  • Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M . 1999 Cancer Res. 59: 5917–5921

  • Kyo S, Takakura M, Kohama T, Inoue M . 1997 Telomerase activity in human endometrium Cancer Res. 57: 610–614

  • Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M . 2000 Nucleic Acids Res. 28: 669–677

  • Kyo S, Takakura M, Tanaka M, Kanaya T, Inoue M . 1998 Int. J. Cancer 79: 66–70

  • Kyo S, Ueno H, Kanaya T, Inoue M . 1996 Clin. Cancer Res. 2: 2023–2028

  • Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN . 1997 Cell 89: 349–356

  • Li H, Zhao LL, Funder JW, Liu JP . 1997 J. Biol. Chem. 272: 16729–16732

  • Li H, Zhao L, Yang Z, Funder JW, Liu JP . 1998 J. Biol. Chem. 273: 33436–33442

  • Liu K, Hodes RJ, Weng NP . 2001 J. Immunol. 166: 4826–4830

  • Marks PA, Richon VM, Rifkind RA . 2000 J. Natl. Cancer Inst. 92: 1210–1216

  • Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K, Murakami S . 2000 J. Biol. Chem. 275: 22568–22573

  • Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA . 1997 Cell 90: 785–795

  • Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR . 1997 Science 277: 955–959

  • Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F . 1998 Nat. Genet. 18: 65–68

  • Oh S, Song YH, Yim J, Kim TK . 1999 J. Biol. Chem. 274: 37473–37478

  • Oh S, Song YH, Yim J, Kim TK . 2000 Oncogene 19: 1485–1490

  • Oh ST, Kyo S, Laimins LA . 2001 J. Virol. 75: 5559–5566

  • Richon VM, Sandhoff TW, Rifkind RA, Marks PA . 2000 Proc. Natl. Acad. Sci. USA 97: 10014–10019

  • Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA . 1999 Cell 96: 701–712

  • Sawa H, Kamada H, Ohshima TA, Noguchi A, Itoh N, Saruta K, Hara M, Saito I . 1999 J. Neurooncol. 42: 45–57

  • Shay JW, Bacchetti S . 1997 Eur. J. Cancer 33: 787–791

  • Snijders PJ, van Duin M, Walboomers JM, Steenbergen RD, Risse EK, Helmerhorst TJ, Verheijen RH, Meijer CJ . 1998 Cancer Res. 58: 3812–3818

  • Soda H, Raymond E, Sharma S, Lawrence R, Davidson K, Oka M, Kohno S, Izbicka E, Von Hoff DD . 2000 Prostate 43: 161–168

  • Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H, Sakai T . 1999 59: 4266–4270

  • Stein GS, Montecino M, van Wijnen AJ, Stein JL, Lian JB . 2000 Cancer Res. 60: 2067–2076

  • Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M . 1999 Cancer Res. 59: 551–557

  • Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M . 1998 Cancer Res. 58: 1558–1561

  • Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, Tanaka M, Inoue M . 2001 Nucleic Acids Res. 29: 3006–3011

  • Tanaka M, Kyo S, Takakura M, Kanaya T, Sagawa T, Yamashita K, Okada Y, Hiyama E, Inoue M . 1998 Am. J. Pathol. 153: 1985–1991

  • Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR . 1998 Cancer Res. 58: 4168–4172

  • Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR . 2000 Int. J. Cancer 85: 330–335

  • Veldman T, Horikawa I, Barrett JC, Schlegel R . 2001 J. Virol. 75: 4467–4472

  • Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, Inoue M . 2000 Cancer Res. 60: 5376–5381

  • Wang J, Xie LY, Allan S, Beach D, Hannon GJ . 1998 Genes Dev. 12: 1769–1774

  • Watson JD . 1972 Nat. New. Biol. 239: 197–201

  • Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB . 1997 Nat. Genet. 17: 498–502

  • Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R . 1999 Nat. Genet. 21: 220–224

  • Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M . 2001 Proc. Natl. Acad. Sci. USA 98: 3826–3831

  • Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG, Pisa P . 2000 Oncogene 19: 5123–5133

  • Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T, Utakoji T . 1996 Oncogene 13: 433–439

  • Yi X, White DM, Aisner D, Baur JA, Wright WE, Shay JW . 2000 Neoplasia 2: 433–440

  • Zhang W, Kapusta LR, Slingerland JM, Klotz LH . 1998 Cancer Res. 58: 619–621

  • Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R . 1996 Proc. Natl. Acad. Sci. USA 93: 6091–6095

Download references

Acknowledgements

We thank Professor Jerry Shay for configuring the manuscript and providing helpful advice and discussion.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoru Kyo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kyo, S., Inoue, M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy?. Oncogene 21, 688–697 (2002). https://doi.org/10.1038/sj.onc.1205163

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205163

Keywords

This article is cited by

Search

Quick links